Vertex to Announce Third Quarter 2022 Financial Results on October 27
2022年10月14日 - 5:05AM
ビジネスワイヤ(英語)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its third quarter 2022 financial results on Thursday, October 27,
2022 after the financial markets close. The company will host a
conference call and webcast at 4:30 p.m. ET. To access the call,
please dial (877) 270-2148 (U.S.) or +1(412) 902-6510
(International) and reference the “Vertex Pharmaceuticals Third
Quarter 2022 Earnings Call”.
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has multiple approved medicines
that treat the underlying cause of cystic fibrosis (CF) — a rare,
life-threatening genetic disease — and has several ongoing clinical
and research programs in CF. Beyond CF, Vertex has a robust
pipeline of investigational small molecule, cell and genetic
therapies in other serious diseases where it has deep insight into
causal human biology, including sickle cell disease, beta
thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes,
alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London. Additionally, the company
has research and development sites and commercial offices in North
America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 12 consecutive years on Science magazine's Top
Employers list and one of the 2022 Seramount 100 Best Companies.
For company updates and to learn more about Vertex's history of
innovation, visit www.vrtx.com or follow us on Facebook, Twitter,
LinkedIn, YouTube and Instagram.
(VRTX-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221013005726/en/
Vertex Pharmaceuticals Incorporated Investor Relations:
Susie Lisa, +1 617-341-6108 Or Manisha Pai, +1 617-961-1899 Or
Miroslava Minkova, +1 617-341-6135
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 6 2024 まで 7 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 7 2023 まで 7 2024